Intellia Therapeutics, Inc. (NTLA)
13.49
-0.05
(-0.37%)
USD |
NASDAQ |
Jun 08, 16:00
13.70
+0.21
(+1.56%)
Pre-Market: 08:38
Intellia Therapeutics Profit Margin (Quarterly) : -639.5% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -297.2% |
| Twist Bioscience Corp. | -39.76% |
| Tenaya Therapeutics, Inc. | -8.57K% |
| HCW Biologics Inc. | 30.32% |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.80% |
| Return on Assets | -44.73% |
| Return on Invested Capital | -48.96% |
| Gross Profit Margin (Quarterly) | 85.37% |
| Operating Margin (Quarterly) | -668.1% |
| Return on Net Operating Assets | -252.3% |